GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Aurora Cannabis Inc (NAS:ACB) » Definitions » COGS-to-Revenue
中文

Aurora Cannabis (Aurora Cannabis) COGS-to-Revenue : 0.69 (As of Dec. 2023)


View and export this data going back to 2014. Start your Free Trial

What is Aurora Cannabis COGS-to-Revenue?

Aurora Cannabis's Cost of Goods Sold for the three months ended in Dec. 2023 was $33.3 Mil. Its Revenue for the three months ended in Dec. 2023 was $48.0 Mil.

Aurora Cannabis's COGS to Revenue for the three months ended in Dec. 2023 was 0.69.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. Aurora Cannabis's Gross Margin % for the three months ended in Dec. 2023 was 30.74%.


Aurora Cannabis COGS-to-Revenue Historical Data

The historical data trend for Aurora Cannabis's COGS-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Aurora Cannabis COGS-to-Revenue Chart

Aurora Cannabis Annual Data
Trend Jun12 Jun13 Jun14 Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21
COGS-to-Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.11 0.21 0.42 1.07 1.09

Aurora Cannabis Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
COGS-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.26 0.71 0.67 0.46 0.69

Aurora Cannabis COGS-to-Revenue Calculation

Aurora Cannabis's COGS to Revenue for the fiscal year that ended in Jun. 2021 is calculated as

COGS to Revenue=Cost of Goods Sold / Revenue
=218.339 / 200.697
=1.09

Aurora Cannabis's COGS to Revenue for the quarter that ended in Dec. 2023 is calculated as

COGS to Revenue=Cost of Goods Sold / Revenue
=33.256 / 48.017
=0.69

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Aurora Cannabis  (NAS:ACB) COGS-to-Revenue Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

Aurora Cannabis's Gross Margin % for the three months ended in Dec. 2023 is calculated as:

Gross Margin %=1 - COGS to Revenue
=1 - Cost of Goods Sold / Revenue
=1 - 33.256 / 48.017
=30.74 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.


Aurora Cannabis COGS-to-Revenue Related Terms

Thank you for viewing the detailed overview of Aurora Cannabis's COGS-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Aurora Cannabis (Aurora Cannabis) Business Description

Traded in Other Exchanges
Address
3498 63 Avenue, Leduc, AB, CAN, T9E 0G8
Aurora Cannabis, headquartered in Edmonton, Canada, cultivates and sells medicinal and recreational cannabis through a portfolio of brands that includes Drift, San Rafael '71, Daily Special, Whistler, Being, and Greybeard. Although the company primarily operates in Canada, it has expanded internationally through medical cannabis exporting agreements.